These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12094555)

  • 1. Topoisomerase II inhibitors--teaching old dogs new tricks.
    Sharma S
    Cancer Invest; 2002; 20(4):596-7. PubMed ID: 12094555
    [No Abstract]   [Full Text] [Related]  

  • 2. Topoisomerase II inhibitors.
    Clapp JM; Hande KR
    Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
    [No Abstract]   [Full Text] [Related]  

  • 3. Topoisomerase II inhibitors.
    Toonen TR; Hande KR
    Cancer Chemother Biol Response Modif; 2001; 19():129-47. PubMed ID: 11686011
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
    Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
    Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase expression in tumors--a novel target for chemotherapy.
    Rubin EH
    Hum Pathol; 2000 Jun; 31(6):631-2. PubMed ID: 10872653
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA topoisomerase II as a target for cancer chemotherapy.
    Walker JV; Nitiss JL
    Cancer Invest; 2002; 20(4):570-89. PubMed ID: 12094551
    [No Abstract]   [Full Text] [Related]  

  • 7. From DNA damage to G2 arrest: the many roles of topoisomerase II.
    Larsen AK; Escargueil AE; Skladanowski A
    Prog Cell Cycle Res; 2003; 5():295-300. PubMed ID: 14593724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN-10755. Menarini.
    Jones K
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1473-8. PubMed ID: 14763135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topoisomerase II as a cellular receptor of various antineoplastic drugs].
    Szmigiero L
    Postepy Biochem; 1988; 34(3):147-52. PubMed ID: 2855749
    [No Abstract]   [Full Text] [Related]  

  • 11. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
    Shuai L; Wang S; Zhang L; Fu B; Zhou X
    Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
    Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
    Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerases of kinetoplastid parasites: why so fascinating?
    Das BB; Sengupta T; Ganguly A; Majumder HK
    Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical structural motif for the catalytic inhibition of human topoisomerase II by UK-1 and analogs.
    Wang BB; Maghami N; Goodlin VL; Smith PJ
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3221-6. PubMed ID: 15149679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.
    Furet P; Schoepfer J; Radimerski T; Chène P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4014-7. PubMed ID: 19560355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging DNA topisomerase inhibitors as anticancer drugs.
    Denny WA
    Expert Opin Emerg Drugs; 2004 May; 9(1):105-33. PubMed ID: 15155139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding topoisomerase I and II in terms of QSAR.
    Verma RP
    Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
    Han S; Xiao Z; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel homogenous assay for topoisomerase II action and inhibition.
    Jahnz M; Medina MA; Schwille P
    Chembiochem; 2005 May; 6(5):920-6. PubMed ID: 15812853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.